✦ LIBER ✦

ACMG Standards and Guidelines for fragile X testing: a revision to the disease-specific supplements to the Standards and Guidelines for Clinical Genetics Laboratories of the American College of Medical Genetics and Genomics

✍ Scribed by Monaghan, Kristin G.; Lyon, Elaine; Spector, Elaine B.

Book ID: 120449590
Publisher: Nature Publishing Group
Year: 2013
Tongue: English
Weight: 727 KB
Volume: 15
Category: Article
ISSN: 1098-3600
DOI: 10.1038/gim.2013.61

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Technical standards and guidelines: Veno

Technical standards and guidelines: Venous thromboembolism (Factor V Leiden and prothrombin 20210G>A testing): A disease-specific supplement to the standards and guidelines for clinical genetics laboratories

✍ Spector, Elaine B; Grody, Wayne W; Matteson, Carla J; Palomaki, Glenn E; Belliss 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 298 KB

Genetic counseling and testing for Alzhe

Genetic counseling and testing for Alzheimer disease: Joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors

✍ Goldman, Jill S; Hahn, Susan E; Catania, Jennifer Williamson; Larusse-Eckert, Su 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 754 KB

Diagnostic DHPLC Quality Assurance (DDQA

Diagnostic DHPLC Quality Assurance (DDQA): A collaborative approach to the generation of validated and standardized methods for DHPLC-based mutation screening in clinical genetics laboratories

✍ Els Schollen; Elisabeth Dequeker; Shirley McQuaid; Bruno Vankeirsbilck; Genevièv 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 339 KB

Genetic testing in a clinical diagnostic environment must be subject to rigorous quality control procedures, in order to ensure consistency and accuracy of results. Denaturing high performance liquid chromatography (DHPLC) has become a standard prescreening tool for mutation detection, offering very

Screening for, Monitoring, and Treatment

Screening for, Monitoring, and Treatment of Chronic Kidney Disease Stages 1 to 3: A Systematic Review for the U.S. Preventive Services Task Force and for an American College of Physicians Clinical Practice Guideline

✍ Fink, Howard A. 📂 Article 📅 2012 🏛 American College of Physicians 🌐 English ⚖ 240 KB